Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

Adiponectin inhibits oxidative stress in human prostate carcinoma cells.

Lu JP, Hou ZF, Duivenvoorden WC, Whelan K, Honig A, Pinthus JH.

Prostate Cancer Prostatic Dis. 2012 Mar;15(1):28-35. doi: 10.1038/pcan.2011.53. Epub 2012 Jan 17.

PMID:
22249290
2.

Maintenance of redox state and pancreatic beta-cell function: role of leptin and adiponectin.

Chetboun M, Abitbol G, Rozenberg K, Rozenfeld H, Deutsch A, Sampson SR, Rosenzweig T.

J Cell Biochem. 2012 Jun;113(6):1966-76. doi: 10.1002/jcb.24065.

PMID:
22253064
3.

Androgen induces adaptation to oxidative stress in prostate cancer: implications for treatment with radiation therapy.

Pinthus JH, Bryskin I, Trachtenberg J, Lu JP, Singh G, Fridman E, Wilson BC.

Neoplasia. 2007 Jan;9(1):68-80.

4.

A NADPH oxidase-dependent redox signaling pathway mediates the selective radiosensitization effect of parthenolide in prostate cancer cells.

Sun Y, St Clair DK, Xu Y, Crooks PA, St Clair WH.

Cancer Res. 2010 Apr 1;70(7):2880-90. doi: 10.1158/0008-5472.CAN-09-4572. Epub 2010 Mar 16.

5.

Cellular repair of oxidatively induced DNA base lesions is defective in prostate cancer cell lines, PC-3 and DU-145.

Trzeciak AR, Nyaga SG, Jaruga P, Lohani A, Dizdaroglu M, Evans MK.

Carcinogenesis. 2004 Aug;25(8):1359-70. Epub 2004 Mar 25.

6.

Enhanced ROS production by NADPH oxidase is correlated to changes in antioxidant enzyme activity in human heart failure.

Borchi E, Bargelli V, Stillitano F, Giordano C, Sebastiani M, Nassi PA, d'Amati G, Cerbai E, Nediani C.

Biochim Biophys Acta. 2010 Mar;1802(3):331-8. doi: 10.1016/j.bbadis.2009.10.014. Epub 2009 Nov 3.

7.

The PPARgamma ligand, rosiglitazone, reduces vascular oxidative stress and NADPH oxidase expression in diabetic mice.

Hwang J, Kleinhenz DJ, Rupnow HL, Campbell AG, Thulé PM, Sutliff RL, Hart CM.

Vascul Pharmacol. 2007 Jun;46(6):456-62. Epub 2007 Feb 8.

PMID:
17337254
8.

Berberine inhibits NADPH oxidase mediated superoxide anion production in macrophages.

Sarna LK, Wu N, Hwang SY, Siow YL, O K.

Can J Physiol Pharmacol. 2010 Mar;88(3):369-78. doi: 10.1139/Y09-136.

PMID:
20393601
9.
10.

Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress.

Tao L, Gao E, Jiao X, Yuan Y, Li S, Christopher TA, Lopez BL, Koch W, Chan L, Goldstein BJ, Ma XL.

Circulation. 2007 Mar 20;115(11):1408-16. Epub 2007 Mar 5.

11.

Transcriptional upregulation of mitochondrial uncoupling protein 2 protects against oxidative stress-associated neurogenic hypertension.

Chan SH, Wu CA, Wu KL, Ho YH, Chang AY, Chan JY.

Circ Res. 2009 Oct 23;105(9):886-96. doi: 10.1161/CIRCRESAHA.109.199018. Epub 2009 Sep 17.

12.

Increased oxidative stress in lambs with increased pulmonary blood flow and pulmonary hypertension: role of NADPH oxidase and endothelial NO synthase.

Grobe AC, Wells SM, Benavidez E, Oishi P, Azakie A, Fineman JR, Black SM.

Am J Physiol Lung Cell Mol Physiol. 2006 Jun;290(6):L1069-77.

13.

Nitric oxide and oxidative stress in vascular disease.

Förstermann U.

Pflugers Arch. 2010 May;459(6):923-39. doi: 10.1007/s00424-010-0808-2. Epub 2010 Mar 21. Review.

PMID:
20306272
14.

Oxidative stress and increased eNOS and NADPH oxidase expression in mouse microvessel endothelial cells.

Ding H, Aljofan M, Triggle CR.

J Cell Physiol. 2007 Sep;212(3):682-9.

PMID:
17443690
15.

Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype.

Kumar B, Koul S, Khandrika L, Meacham RB, Koul HK.

Cancer Res. 2008 Mar 15;68(6):1777-85. doi: 10.1158/0008-5472.CAN-07-5259.

16.

Adiponectin improves endothelial function in hyperlipidemic rats by reducing oxidative/nitrative stress and differential regulation of eNOS/iNOS activity.

Li R, Wang WQ, Zhang H, Yang X, Fan Q, Christopher TA, Lopez BL, Tao L, Goldstein BJ, Gao F, Ma XL.

Am J Physiol Endocrinol Metab. 2007 Dec;293(6):E1703-8. Epub 2007 Sep 25.

17.
19.

Adiponectin suppresses proliferation and superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDL.

Motoshima H, Wu X, Mahadev K, Goldstein BJ.

Biochem Biophys Res Commun. 2004 Mar 5;315(2):264-71.

PMID:
14766203
20.

Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells.

Ripple MO, Henry WF, Rago RP, Wilding G.

J Natl Cancer Inst. 1997 Jan 1;89(1):40-8.

Items per page

Supplemental Content

Write to the Help Desk